相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Advanced MalignantMelanoma: Immunologic and Multimodal Therapeutic Strategies
Niels Halama et al.
JOURNAL OF ONCOLOGY (2010)
The involvement of the transcription factor Yin Yang 1 in cancer development and progression
Giancarlo Castellano et al.
CELL CYCLE (2009)
Naproxcinod, a new cyclooxygenase-inhibiting nitric oxide donator (CINOD)
Piet Geusens
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Increasing Burden of Melanoma in the United States
Eleni Linos et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt
Danijela Maksimovic-Ivanic et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Anti-HIV drugs for cancer therapeutics: back to the future?
Warren A. Chow et al.
LANCET ONCOLOGY (2009)
Cell fate decisions are specified by the dynamic ERK interactome
Alex von Kriegsheim et al.
NATURE CELL BIOLOGY (2009)
Nitric oxide sensitizes tumor cells to TRAIL-induced apoptosis via inhibition of the DR5 transcription repressor Yin Yang 1
Sara Huerta-Yepez et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2009)
An in vivo model of melanoma: treatment with ATP
Nicholas White et al.
PURINERGIC SIGNALLING (2009)
TRAIL receptor-targeted therapeutics: Resistance mechanisms and strategies to avoid them
Andrew Thorburn et al.
DRUG RESISTANCE UPDATES (2008)
Withaferin A inhibits NOS expression and nitric oxide production by Akt inactivation and down-regulating LPS-induced activity of NF-κB in RAW 264.7 cells
Jung Hwa Oh et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Nitric oxide activated by p38 and NF-kappa B facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells
Jia Yang et al.
FREE RADICAL RESEARCH (2008)
Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling
Hideko Hayashi et al.
GENES TO CELLS (2008)
Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways
Soon-Tae Lee et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
Danijela Maksimovic-Ivanic et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Constitutive intracellular production of iNOS and NO in human melanoma: possible role in regulation of growth and resistance to apoptosis
Elizabeth A. Grimm et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide (GIT-27NO) induces p53 mediated apoptosis in human A375 melanoma cells
Sanja Mijatovic et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2008)
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition
D Krubasik et al.
BRITISH JOURNAL OF CANCER (2006)
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
S Gordon et al.
ONCOGENE (2006)
Centaurin-α1 is a phosphatidylinositol 3-kinase-dependent activator of ERK1/2 mitogen-activated protein kinases
H Hayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Benzodiazepinedione inhibitors of the Hdm2 : p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo
HK Koblish et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation
F Hongo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
HIV protease inhibitors block Akt signaling and radiosensitize tumor cells both in vitro and in vivo
AK Gupta et al.
CANCER RESEARCH (2005)
Novel platinum(IV) complexes induce rapid tumor cell death in vitro
GN Kaludjerovic et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism
F Pajonk et al.
BMC CANCER (2005)
Proteasome inhibitor MG132 induces death receptor 5 through CCAAT/enhancer-binding protein homologous protein
T Yoshida et al.
CANCER RESEARCH (2005)
Anti-glioma action of aloe emodin: the role of ERK inhibition
S Mijatovic et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro
E Unni et al.
BREAST CANCER RESEARCH (2005)
Genomic alterations in spontaneous and carcinogen-induced murine melanoma cell lines
VO Melnikova et al.
ONCOGENE (2004)
Contributions of CYP3A4, P-glycoprotein, and serum protein binding to the intestinal first-pass extraction of saquinavir
SJ Mouly et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53-dependent manner in melanoma cell lines
CH Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Attenuation of small-for-size liver graft injury by FTY720: Significance of cell survival Akt signaling pathway
Y Zhao et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells
M Schütt et al.
JOURNAL OF ENDOCRINOLOGY (2004)
Nitric-oxide-donating NSAIDs as agents for cancer prevention
B Rigas et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Suppression of NF-κB survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL
M Chawla-Sarkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth
C Sgadari et al.
LANCET ONCOLOGY (2003)
Long-term exposure to lifelong therapies
WG Powderly
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2002)
Galectin-3 and metastasis
Y Takenaka et al.
GLYCOCONJUGATE JOURNAL (2002)
How melanoma cells evade trail-induced apoptosis
P Hersey et al.
NATURE REVIEWS CANCER (2001)
A critical pole for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of Ras and mitogen-activated protein kinases by epidermal growth factor
A Yart et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)